We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines.
Guidance for prescribing vets on the use of the cascade.
News and guidance on veterinary medicines issues affected by coronavirus (COVID-19).
Information for patients who have been prescribed Lagevrio (molnupiravir), the COVID-19 oral antiviral medication.
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Jan - 31 Mar 2024.
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Professional conduct panel outcome, including decision and reasons.
Check the tariff classification for articles made of cermet.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
You must tell DVLA if you have a brain abscess, cyst or encephalitis - download the correct form to let them know
Information on carrying medicine containing controlled drugs for individual travellers entering or leaving the UK.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
Guidance for commissioners and health professionals to make decisions about mental health services and interventions based on data and analysis.
The characteristics, diagnosis, management, surveillance and epidemiology of meningococcal disease.
Fifteen additional synthetic opioids are now under the strictest controls to prevent drug related deaths and ensure anyone caught supplying them faces tough penalties.
Advice for medical professionals to follow when assessing drivers with psychiatric disorders.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.